O-111 Docetaxel and COX-2 inhibition with celecoxib in progressive non-small cell lung cancer (NSCLC): Promising progression-free survival in a phase II study
- 1 August 2003
- journal article
- abstracts
- Published by Elsevier in Lung Cancer
- Vol. 41, S35-S36
- https://doi.org/10.1016/s0169-5002(03)91769-7
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: